Multimodal, Point of Care, Commercial partner, Molecular diagnostics, Immunoassays, Cytometry, Chemistry, POCT, PCR, LFA,
1. Novel Technologies for Prevention, Detection, Assessment and Management of Animal Health and Welfare
Fluxergy is willing to leverage its point-of-care consumable and analyzer manufacturing expertise, manufacturing facilities, and assay development, integration and manufacturing resources to align with assay and reagent development companies and researchers to develop impactful multiplex or multimodal point-of-care that will improve field testing capabilities for burdensome zoonotic and animal diseases.
Fast, accurate and reliable information leads to better data which leads to better choices. As the first open platform for multimodal, point-of-care assay development and testing, we’re making our technology accessible through a collaborative model that allows custom Implementation of assays, which will enable us to deliver thousands of assays for communities and markets around the world.
